CN1058288C - 一种隐孔菌菌粉的生产方法 - Google Patents
一种隐孔菌菌粉的生产方法 Download PDFInfo
- Publication number
- CN1058288C CN1058288C CN 94117227 CN94117227A CN1058288C CN 1058288 C CN1058288 C CN 1058288C CN 94117227 CN94117227 CN 94117227 CN 94117227 A CN94117227 A CN 94117227A CN 1058288 C CN1058288 C CN 1058288C
- Authority
- CN
- China
- Prior art keywords
- nutrient solution
- cryptoporus volvatus
- culture
- cryptoporus
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000843 powder Substances 0.000 title claims abstract description 55
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 15
- 241000123291 Cryptoporus volvatus Species 0.000 title claims description 68
- 238000000034 method Methods 0.000 claims abstract description 28
- 238000009423 ventilation Methods 0.000 claims abstract description 14
- 239000001963 growth medium Substances 0.000 claims abstract description 9
- 238000010899 nucleation Methods 0.000 claims abstract description 7
- 238000007873 sieving Methods 0.000 claims abstract description 6
- 235000015097 nutrients Nutrition 0.000 claims description 46
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 24
- 239000008103 glucose Substances 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 239000007788 liquid Substances 0.000 claims description 22
- 230000001954 sterilising effect Effects 0.000 claims description 18
- 238000004659 sterilization and disinfection Methods 0.000 claims description 18
- 229940041514 candida albicans extract Drugs 0.000 claims description 13
- 210000000582 semen Anatomy 0.000 claims description 13
- 239000012138 yeast extract Substances 0.000 claims description 13
- 239000001888 Peptone Substances 0.000 claims description 12
- 108010080698 Peptones Proteins 0.000 claims description 12
- 235000019319 peptone Nutrition 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 11
- 240000008042 Zea mays Species 0.000 claims description 11
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 11
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 11
- 235000005822 corn Nutrition 0.000 claims description 11
- 229920001817 Agar Polymers 0.000 claims description 6
- 230000004913 activation Effects 0.000 claims description 6
- 239000008272 agar Substances 0.000 claims description 6
- 238000000855 fermentation Methods 0.000 claims description 6
- 230000004151 fermentation Effects 0.000 claims description 6
- 239000012065 filter cake Substances 0.000 claims description 6
- 230000010355 oscillation Effects 0.000 claims description 6
- 238000012807 shake-flask culturing Methods 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 4
- 238000010298 pulverizing process Methods 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 241000123288 Cryptoporus Species 0.000 abstract description 6
- 239000012531 culture fluid Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 29
- 241000233866 Fungi Species 0.000 description 14
- 239000003814 drug Substances 0.000 description 14
- 239000011148 porous material Substances 0.000 description 13
- 208000006673 asthma Diseases 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 238000012360 testing method Methods 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 244000215068 Acacia senegal Species 0.000 description 2
- 235000006491 Acacia senegal Nutrition 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 2
- 208000037656 Respiratory Sounds Diseases 0.000 description 2
- 206010047924 Wheezing Diseases 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 2
- 231100000053 low toxicity Toxicity 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- CUCUKLJLRRAKFN-UHFFFAOYSA-N 7-Hydroxy-(S)-usnate Chemical compound CC12C(=O)C(C(=O)C)C(=O)C=C1OC1=C2C(O)=C(C)C(O)=C1C(C)=O CUCUKLJLRRAKFN-UHFFFAOYSA-N 0.000 description 1
- 208000009079 Bronchial Spasm Diseases 0.000 description 1
- 208000014181 Bronchial disease Diseases 0.000 description 1
- 206010006482 Bronchospasm Diseases 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 241000222383 Polyporales Species 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 238000010564 aerobic fermentation Methods 0.000 description 1
- 201000009961 allergic asthma Diseases 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 230000002804 anti-anaphylactic effect Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical group C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Natural products O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 1
- -1 morphine monomethyl ethers Chemical class 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
组别 | 动物数只 | 剂量克/公斤 | 咳嗽 次数次/分X±SD | P值 | 镇咳百分率(%) |
对照组可待因组小剂量组大剂量组 | 891010 | 1※50※※1.182.38 | 11.12±10.380.66±1.411.6±2.061.1±1.72 | <0.05<0.05<0.05 | 94.0685.6190.10 |
组别 | 动物数 | 剂量(克/公斤) | 洗出液酚红浓度(微克/毫升)X±SD | P值 |
对照组 | 9 | 1※ | 2.23±0.81 | |
小剂量组 | 8 | 1.19 | 3.94±0.76 | <0.01 |
中剂量组 | 9 | 2.38 | 4.11±2.73 | <0.01 |
高剂量组 | 9 | 4.76 | 6.31±3.25 | <0.01 |
组别 | 动物数 | 剂量(克/公斤) | III级反应潜伏期T2-T1(S)X±SD | P值 |
菌粉水煎液I | 7 | 0.156 | 7.4±44.1 | >0.05 |
菌粉水煎液II | 9 | 0.208 | 35.55±43.11 | <0.01 |
菌粉水煎液III | 6 | 2.38 | 246.25±71.2 | <0.01 |
组别 | 动物数 | 剂量毫升 | 反应 级数X土SD | P值 |
对照组 | 10 | 2※ | 1.9±0.87 | |
实验组 | 10 | 2※※ | 0.9±0.56 | <0.01 |
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 94117227 CN1058288C (zh) | 1994-10-15 | 1994-10-15 | 一种隐孔菌菌粉的生产方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 94117227 CN1058288C (zh) | 1994-10-15 | 1994-10-15 | 一种隐孔菌菌粉的生产方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1121111A CN1121111A (zh) | 1996-04-24 |
CN1058288C true CN1058288C (zh) | 2000-11-08 |
Family
ID=5038246
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 94117227 Expired - Fee Related CN1058288C (zh) | 1994-10-15 | 1994-10-15 | 一种隐孔菌菌粉的生产方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1058288C (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003025155A1 (fr) * | 2001-08-17 | 2003-03-27 | Hangzhou Tsbio Science & Technology Co., Ltd. | Produit de fermentation de cryptoporus volvatus et son procede de preparation et utilisation |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102920748B (zh) * | 2012-11-15 | 2014-04-16 | 中国农业大学 | 隐孔菌在制备治疗猪繁殖与呼吸综合征产品中的应用 |
CN102920747B (zh) * | 2012-11-15 | 2014-04-16 | 中国农业大学 | 隐孔菌在制备抑制猪繁殖与呼吸综合征病毒产品中的应用 |
CN105559045B (zh) * | 2015-12-23 | 2018-04-20 | 河南省农业科学院植物营养与资源环境研究所 | 一种羊肚菌营养粉的制备方法 |
CN108070529A (zh) * | 2018-01-18 | 2018-05-25 | 杭州科格生物科技有限公司 | 一种固态培养隐孔菌菌粉的生产方法及其应用 |
CN109496683B (zh) * | 2018-11-30 | 2021-07-30 | 宜章县福城生物科技开发有限公司 | 匀质分散型食用菌菌种的制种方法 |
-
1994
- 1994-10-15 CN CN 94117227 patent/CN1058288C/zh not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003025155A1 (fr) * | 2001-08-17 | 2003-03-27 | Hangzhou Tsbio Science & Technology Co., Ltd. | Produit de fermentation de cryptoporus volvatus et son procede de preparation et utilisation |
Also Published As
Publication number | Publication date |
---|---|
CN1121111A (zh) | 1996-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1195843C (zh) | 樟芝的固体培养方法,所得固体培养物及其产品与用途 | |
CN1757743A (zh) | 含异黄酮的组合物 | |
CN1856568A (zh) | 发酵和培养的方法、植物发酵提取物、植物发酵提取物粉末以及含有植物发酵提取物的组合物 | |
CN1799562A (zh) | 一种樟芝菌丝体发酵提取物及其应用 | |
CN101029300A (zh) | 一种降酸酵母及其在杨梅果酒酿造中的应用 | |
CN1799560A (zh) | 一种抗肝癌的樟芝胶囊及其制备方法 | |
CN1283778C (zh) | N6-(2-羟乙基)腺苷在制备镇痛药物中的应用 | |
CN1058288C (zh) | 一种隐孔菌菌粉的生产方法 | |
CN1799561A (zh) | 樟芝菌丝体发酵提取物在制备抗辐射损伤药物中的应用 | |
CN109207371B (zh) | 一种生产灵芝的分段发酵方法 | |
CN110684672A (zh) | 一种抗氧化蝉花菌丝体的发酵方法 | |
CN1028542C (zh) | 新的抗瘤抗生素物质生产方法 | |
CN1320099C (zh) | 利用北里孢菌PL6-3制备ε-聚赖氨酸及其盐的方法 | |
CN103214593A (zh) | β-葡聚糖的制备方法 | |
CN1854288A (zh) | 可高产糖肽复合物的灵芝真菌及其诱变选育方法和用途 | |
CN101067120A (zh) | 粪肠球菌cms-h001及其应用 | |
CN1569903A (zh) | 酶解制备灵芝多糖的方法 | |
CN1752109A (zh) | 酶解制备灰树花多糖的方法 | |
CN1884386A (zh) | 竹黄菌发酵制备天然蒽醌类色素的方法 | |
CN1536069A (zh) | 大规模生产虫草菌和灵芝菌的方法 | |
CN1225163C (zh) | 含喜树碱的喜树愈伤组织培养方法 | |
CN1924010A (zh) | 食用菌菌糠超氧化物歧化酶提取工艺 | |
CN1375216A (zh) | 一种用作饲料添加剂的菌酶制剂协同发酵工艺 | |
CN1827633A (zh) | 从蝉拟青霉培养物中提取n6-(2-羟乙基)腺苷的方法 | |
CN1563398A (zh) | 一种雅致放射毛霉用于生产神经酰胺的用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: ZHEJIANG CI FU MEDICINE CO., LTD. Free format text: FORMER OWNER: HUA QIHONG Free format text: FORMER OWNER: JIN GUOLIANG SUN JING Effective date: 20050401 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20050401 Address after: 310053 Zhejiang province Binjiang District Lake Road 1338 Patentee after: Zhejiang Cifu Pharmaceutical Co., Ltd. Address before: 310004, Hangzhou stadium, No. 152, Stadium Road, Zhejiang, Hangzhou, 10-2-402 Co-patentee before: Jin Guoliang Patentee before: Hua Qihong Co-patentee before: Sun Jing |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20001108 Termination date: 20101015 |